| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/18/2013 | CN101421306B Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer |
| 09/18/2013 | CN101134102B 5T4 antigen-expressed vector |
| 09/17/2013 | US8536312 Monoclonal antibodies with specificity for fetal erythroid cells |
| 09/17/2013 | US8536311 Inhibitor protein of the wnt signal pathway |
| 09/17/2013 | US8536307 Anticalins |
| 09/17/2013 | US8536306 Human A2A adenosine receptor crystals and uses thereof |
| 09/17/2013 | US8536304 Tumour-associated peptides that bind to MHC molecules |
| 09/17/2013 | US8536149 TRPM-2 antisense therapy |
| 09/17/2013 | US8536145 Introducing genetic material topically or by lavage into mucosal tissue cells of an individual, including rectal, vaginal, urethral, sublingual and buccal; used to deliver genetic material that encodes protein targets for immunization against pathogen infection, hyperproliferative or autoimmune diseases |
| 09/17/2013 | US8536136 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/17/2013 | US8536126 Conjugated factor VIII molecules |
| 09/17/2013 | US8536123 Use of blood flow parameters to monitor or control the dosing of erythropoiesis-stimulating agents |
| 09/17/2013 | US8536122 Acylated GLP-1 compounds |
| 09/17/2013 | US8536119 Synthesis of fluorescent metal nanoclusters |
| 09/17/2013 | US8536115 Compositions and methods for modulating AMPA receptor-mediated excitotoxicity |
| 09/17/2013 | US8535912 Chimeric fibroblast growth factors with altered receptor specificity |
| 09/17/2013 | US8535911 Cell with improved secretion mediated by MrgA protein or homologue |
| 09/17/2013 | US8535899 Assay for identifying a modulator of HIF hydroxylase |
| 09/17/2013 | US8535898 Thrombin substrate and assay for determining the level of bioactive thrombin in a sample |
| 09/17/2013 | US8535893 Resistance to auxinic herbicides |
| 09/17/2013 | US8535892 Binding molecules for human factor VIII and factor VIII-like proteins |
| 09/17/2013 | US8535884 LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis |
| 09/17/2013 | US8535690 Tumor specific animal proteins |
| 09/17/2013 | US8535685 H3 equine influenza A virus |
| 09/17/2013 | US8535681 Sustained drug delivery system |
| 09/17/2013 | US8535673 A humanized antibody that specifically binds an epitope contained within positions 13-28 of A beta; used for treating Alzheimer's disease in both asymptomatic patients and those currently showing symptoms of disease. |
| 09/17/2013 | US8535672 Superantigen binding site wherein T-cell costimulatory pathway is one of CD28/B7 T cell costimulatory pathway, CD40 ligand/CD40, CD2/CD58 and LFA-1 (CD18)/ICAM-1 (CD54) costimulatory pathway; toxic shock syndrome caused by a pyrogenic exotoxin; anticarcinogenic and antiproliferative agents |
| 09/17/2013 | US8535666 Antibody (11C7) anti Nogo-A and its pharmaceutical use |
| 09/17/2013 | US8535663 Method for treating delayed-type hypersensitivity |
| 09/17/2013 | CA2645701C Process for obtaining a concentrate of von willebrand factor or a complex of factor viii/von willebrand factor and use of the same |
| 09/17/2013 | CA2563887C Mite allergen zen 1 |
| 09/17/2013 | CA2562711C Cab molecules |
| 09/17/2013 | CA2546794C Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 09/17/2013 | CA2534748C Relaxin superfamily peptide analogues |
| 09/17/2013 | CA2533789C Epha2 t-cell epitope agonists and uses therefor |
| 09/17/2013 | CA2518811C Plant cells and plant bodies with modified cell growth, development and differentiation |
| 09/17/2013 | CA2516519C Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/17/2013 | CA2482946C Multi plasmid system for the production of influenza virus |
| 09/17/2013 | CA2438074C Process for production of polypeptides |
| 09/17/2013 | CA2423093C Improved system for regulation of transgene expression |
| 09/17/2013 | CA2402380C Leafy cotyledon2 genes and their uses |
| 09/17/2013 | CA2348382C Chimeric parvovirus vectors and methods of making and administering the same |
| 09/17/2013 | CA2285701C .beta.-catenin, tcf-4, and apc interact to prevent cancer |
| 09/12/2013 | WO2013134734A2 Toxic peptide production, peptide expression in plants and combinations of cysteine rich peptides |
| 09/12/2013 | WO2013134577A2 Leishmaniasis antigen detection assays and vaccines |
| 09/12/2013 | WO2013134535A1 Axmi345 delta-endotoxin gene and methods for its use |
| 09/12/2013 | WO2013134523A1 Bacillus thuringiensis toxin gene axmi335 and methods for its use |
| 09/12/2013 | WO2013134295A1 Identification of channelrhodopsin-2 (chop2) mutations and methods of use |
| 09/12/2013 | WO2013134269A2 New compositions, the preparation and use thereof |
| 09/12/2013 | WO2013134249A1 Adipose tissue targeted peptides |
| 09/12/2013 | WO2013134174A2 Recombinant bacteria comprising novel sucrose transporters |
| 09/12/2013 | WO2013134167A1 Variant sucrose transporter polypeptides |
| 09/12/2013 | WO2013134138A1 Engineered antibody-interferon mutant fusion molecules |
| 09/12/2013 | WO2013132518A1 Recombinant nitrogen fixing microorganism and uses thereof |
| 09/12/2013 | WO2013132505A1 Improved process for preparation of octreotide by solution phase peptide synthesis |
| 09/12/2013 | WO2013132052A1 Compositions comprising secretory - like immunoglobulins |
| 09/12/2013 | WO2013132005A1 Antimicrobial peptides |
| 09/12/2013 | WO2013131991A1 Means and methods for determining neurotoxin activity based on a modified luciferase |
| 09/12/2013 | WO2013131957A1 Membrane span-kinase fusion protein and the uses thereof |
| 09/12/2013 | WO2013131205A1 Plant stomata regulation related protein gabr1 and coding gene and use thereof |
| 09/12/2013 | WO2013106851A3 Syncollin, pancreatic triacylglycerol lipase, and other biomarkers for diabetes |
| 09/12/2013 | WO2012140588A8 Production of heterologous extracellular polypeptides in yarrowia lipolytica |
| 09/12/2013 | WO2012083259A3 Method, system and apparatus for control of pancreatic beta cell function to improve glucose homeostatis and insulin production |
| 09/12/2013 | US20130237689 Soluble hla class ii complexes and methods of production and use thereof |
| 09/12/2013 | US20130237685 Linear assemblies, branched assemblies, macrocycles and covalent bundles of functionalized bis-peptides |
| 09/12/2013 | US20130237684 Reconstituted polypeptides |
| 09/12/2013 | US20130237486 Collagen |
| 09/12/2013 | US20130237484 Human-derived cell-permeable peptide bioactive peptide conjugate, and use thereof |
| 09/12/2013 | US20130237481 Modified relaxin polypeptides and their uses |
| 09/12/2013 | US20130237476 Adipose tissue targeted peptides |
| 09/12/2013 | US20130237475 Synthetic gene for expressing sm-14 in pichia pastoris, methods for producing and purifying sm-14 and the use thereof as a vaccine and diagnostic medium |
| 09/12/2013 | US20130237474 Biosynthetic Polypeptide Fusion Inhibitors |
| 09/12/2013 | US20130237472 Modified human tumor necrosis factor receptor-i polypeptide or fragment thereof, and method for preparing same |
| 09/12/2013 | US20130236930 Process for producing igf-1 polypeptides |
| 09/12/2013 | US20130236911 Hemokinin-1 receptor and hemokinin-1-derived peptide |
| 09/12/2013 | US20130236495 Peptides for modulating t-cell activity and uses therof |
| 09/12/2013 | US20130236491 Spherical nano and microparticles derived from plant viruses for the display of foreign proteins or epitopes |
| 09/12/2013 | US20130236490 Multivalent Vaccine for Filariasis |
| 09/12/2013 | US20130236487 Designer peptide-based pcv2 vaccine |
| 09/12/2013 | US20130236486 Immunogenic vaccine |
| 09/12/2013 | US20130236456 IMMUNOGLOBULIN Fc FRAGMENT TAGGING ACTIVATION OF ENDOGENOUS CD4 AND CD8 T CELLS AND ENHANCEMENT OF ANTITUMOR EFFECTS OF LENTIVECTOR IMMUNIZATION |
| 09/12/2013 | US20130236452 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 09/11/2013 | EP2636739A1 iRNA agents targeting VEGF |
| 09/11/2013 | EP2636736A1 Novel anti-dr5 antibody |
| 09/11/2013 | EP2636682A1 Compositions comprising secretory-like immunoglobulins |
| 09/11/2013 | EP2636680A2 Composition and methods for treatment of congestive heart failure |
| 09/11/2013 | EP2636412A2 Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same |
| 09/11/2013 | EP2635688A1 Densovirus-derived vector for gene transfer in insects |
| 09/11/2013 | EP2635687A2 Modulation of immune responses by the poxviral k4 protein |
| 09/11/2013 | EP2635685A1 Method for increasing yield and fine chemical production in plants |
| 09/11/2013 | EP2635684A1 Plant expression system |
| 09/11/2013 | EP2635682A1 Methods and vectors for cell immortalisation |
| 09/11/2013 | EP2635598A1 Albumin variants |
| 09/11/2013 | EP2635597A1 Information acquisition method |
| 09/11/2013 | EP2635596A1 Immune-modulating agents and uses therefor |
| 09/11/2013 | EP2635595A2 Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
| 09/11/2013 | EP2635594A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| 09/11/2013 | EP2635593A1 Vaccines for preventing meningococcal infections |
| 09/11/2013 | EP2635308A2 Compositions of a peptide targeting system for treating cancer |
| 09/11/2013 | EP2635283A2 Methods for treatment of brain injury utilizing biologics |